Effect of anti-GM-CSF treatment prior to the onset of arthritis
2011-12-30T13:54:42Z (GMT) by
<p><b>Copyright information:</b></p><p>Taken from "Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease"</p><p>Arthritis Research 2001;3(5):293-298.</p><p>Published online 11 Jun 2001</p><p>PMCID:PMC64841.</p><p>Copyright © 2001 Cook et al, licensee BioMed Central Ltd</p> Severity (mean clinical scores ? SEM). Cumulative incidence. Mice were treated intraperitoneally every second day from days 21 to 31 with anti-GM-CSF mAb or control mAb. = 0.05 and = 0.01 compared with control mAb-treated. GM-CSF, Granulocyte macrophage-colony stimulating factor; mAb, monoclonal antibody.